Brainstorm Cell Therapuetics Inc (OTCBB - OTCQB:BCLI)

0.3145
Data as of Aug 29
 +0.0025 / +0.80%
Today’s Change
0.10
Today|||52-Week Range
0.38
+74.72%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Computer Peripherals
MARKET CAP
$70.9M

Company Description

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops innovative adult stem cell therapeutic products. It currently focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NY.

Contact Information

Brainstorm Cell Therapeutics, Inc.
605 3rd Avenue
New York New York 10158
P:(646) 666-3188
Investor Relations:

Employees

Shareholders

Individual stakeholders15.55%
Mutual fund holders--
Other institutional--

Top Executives

Anthony S. FiorinoChief Executive Officer
Chaim LebovitsPresident
Uri YablonkaChief Operating Officer
Liat SossoverChief Financial Officer
Yael GothelfVice President-Scientific & Regulatory Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.